Simran Farms reported a net profit of ₹81.58 lakh for the quarter ended June 30, 2026, representing a 14.2% increase year-on-year from ₹71.46 lakh in Q1FY26. The Indore-based agro-processing firm saw its revenue from operations grow by 4.4% to ₹2,144.3 lakh, up from ₹2,054.6 lakh in the corresponding period of the previous fiscal.

On a consolidated basis, the company recorded a net profit of ₹83.50 lakh, compared to ₹76.17 lakh in Q1FY25. Total comprehensive income for the consolidated entity stood at ₹83.17 lakh, marginally lower than the standalone figure due to other comprehensive income adjustments.

Financial Performance

The company’s pre-tax profit before exceptional items was ₹117.37 lakh on a standalone basis, up from ₹99.72 lakh a year ago. This indicates an improvement in operational profitability despite the modest revenue growth. However, the effective tax rate appears to have increased or remained stable relative to the pre-tax gain, as the post-tax profit growth (14.2%) lagged behind the pre-tax profit growth (17.7%).

What the Numbers Show

A divergence is visible between the company’s absolute profit growth and its earnings per share (EPS) performance. While net profit rose by over 14%, basic EPS fell by nearly 10% to ₹1.70 from ₹1.88. This decline is attributable to the increase in paid-up equity share capital, which expanded to ₹481.0 lakh from ₹379.2 lakh in the previous year. The capital infusion, likely from a rights issue or bonus shares given the significant jump in share count without a corresponding proportional rise in retained earnings (reserves remained at zero), diluted per-share metrics despite stronger bottom-line results.

The full financial results were filed with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also highlighted a regulatory window for investors to re-lodge physical share transfer deeds submitted before April 1, 2019, as per a SEBI circular dated January 30, 2026.

Simran Farms Limited reported a consolidated net profit of ₹508.77 lakh for the financial year ended March 31, 2026, compared to ₹589.61 lakh in the previous year. Total revenue for the year increased to ₹87719.02 lakh from ₹83624.21 lakh in FY25. The company’s board approved the standalone and consolidated audited financial results for the fourth quarter and financial year ended March 31, 2026, in a meeting held on May 30, 2026. The company published extracts of these audited financial results in Free Press Indore (English) and Choutha Sansaar (Hindi) on June 1, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The statutory auditors, M/s Khandelwal Kakani & Company, issued an unmodified opinion on the annual audited standalone and consolidated financial results. The auditors confirmed that the results provide a true and fair view in conformity with the Indian Accounting Standards. The consolidated financial statements include the figures of subsidiary Puregene Biotech Limited.

For the quarter ended March 31, 2026, the company reported a consolidated net profit of ₹283.03 lakh, compared to a net loss of ₹320.92 lakh in the same period last year. Total revenue for the quarter stood at ₹24940.64 lakh, up from ₹23869.66 lakh in the corresponding quarter of the previous year. The profit before tax for the quarter was ₹453.93 lakh.

During the quarter ended March 31, 2026, the company allotted 1018300 equity shares with a face value of ₹10 each against the conversion of 1018300 convertible warrants on a preferential basis. The conversion was executed at an exercise price of ₹155 per share, inclusive of a securities premium of ₹145 per share. This increased the paid-up equity share capital to ₹481.00 lakh as of March 31, 2026.

Financial Performance

The table below summarizes the standalone and consolidated financial results for Simran Farms Limited for the quarter and year ended March 31, 2026.

Assets and Liabilities

As of March 31, 2026, the company’s total consolidated assets stood at ₹17730.86 lakh, a decrease from ₹18945.40 lakh in the previous year. Equity share capital increased to ₹481.00 lakh from ₹379.17 lakh, primarily due to the conversion of warrants. Total equity and liabilities amounted to ₹17730.86 lakh, matching the total assets. Non-current liabilities were recorded at ₹288.04 lakh, while current liabilities stood at ₹11621.96 lakh.